REFERENCES
Austin, M.C., Janosky, J.E., & Murphy, H.A. (2003). Increased
corticotropin-releasing hormone immunoreactivity in monoamine-containing
pontine nuclei of depressed suicide men. Molecular psychiatry ,8 , 324–332.
Binder, E.B., & Nemeroff, C.B. (2010). The CRF system, stress,
depression and anxiety-insights from human genetic studies.Molecular Psychiatry , 15 , 574–588.
Bissette, G., Klimek, V., Pan, J., Stockmeier, C., & Ordway, G. (2003).
Elevated concentrations of CRF in the locus coeruleus of depressed
subjects. Neuropsychopharmacology , 28 , 1328–1335.
Bitran, D., Shiekh, M., Dowd, J.A., Dugan, M.M., & Renda, P. (1998).
Corticosterone is permissive to the anxiolytic effect that results from
the blockade of hippocampal mineralocorticoid receptors.Pharmacology Biochemistry and Behavior , 60 , 879–887.
Chen, J, Gomez-Sanchez, C.E., Penman, A., May, P.J., & Gomez-Sanchez,
E. (2014). Expression of mineralocorticoid and glucocorticoid receptors
in preautonomic neurons of the rat paraventricular nucleus.American Journal of Physiology-Regulatory Integrative and
Comparative Physiology , 306 , R328–R340.
De Kloet, E.R., Vreugdenhil, E., Oitzl, M.S., & Joëls, M. (1998). Brain
Corticosteroid Receptor Balance in Health and Disease. Endocrine
Reviews , 19 , 269–301.
De Souza, E.B. (1995). Corticotropin-releasing factor receptors:
physiology, pharmacology, biochemistry and role in central nervous
system and immune disorders. Psychoneuroendocrinology , 20 ,
789–819.
Deussing, J.M., & Chen, A. (2018). The Corticotropin-Releasing Factor
Family: Physiology of the Stress Response. Physiological Reviews ,98 , 2225–2286.
Ding, H., Cui, X.Y., Cui, S.Y., Ye, H., Hu, X., Zhao, H.L., …
Zhang, Y.H. (2018). Depression-like behaviors induced by chronic
corticosterone exposure via drinking water: Time-course analysis.Neuroscience Letters , 687 , 202–206.
File, S.E., & Seth, P. (2003). A review of 25 years of the social
interaction test. European Journal of Pharmacology , 463 ,
35–53.
Gold, P.W., Gabry, K.E., Yasuda, M.R., & Chrousos, G.P. (2002).
Divergent endocrine abnormalities in melancholic and atypical
depression: clinical and pathophysiologic implications.Endocrinology and Metabolism Clinics of North America , 31 ,
37–62.
Han, F., Ozawa, H., Matsuda, K., Nishi, M., & Kawata, M., (2005).
Colocalization of mineralocorticoid receptor and glucocorticoid receptor
in the hippocampus and hypothalamus. Neuroscience Research ,51 , 371–381.
Herman JP, Adams D, & Prewitt C. (1995). Regulatory changes in
neuroendocrine stress-integrative circuitry produced by a variable
stress paradigm. Neuroendocrinology , 61 , 180–190.
Heuser, I., Bissette, G., Dettling, M., Schweiger, U., Gotthardt, U.,
Schmider, J., … Holsboer, F. (1998). Cerebrospinal fluid
concentrations of corticotropin-releasing hormone, vasopressin, and
somatostatin in depressed patients and healthy controls: response to
amitriptyline treatment. Depression and Anxiety , 8 ,
71–79.
Jadavji, N.M., Supina, R.D., & Metz, G.A. (2011). Blockade of
Mineralocorticoid and Glucocorticoid Receptors Reverses Stress-Induced
Motor Impairments. Neuroendocrinology , 94 , 278–290.
Jiang, Z., Rajamanickam, S., & Justice, N.J. (2019). CRF signaling
between neurons in the paraventricular nucleus of the hypothalamus (PVN)
coordinates stress responses. Neurobiology of Stress , 11, 100192.
Lamberts, S.W.J., Koper, J.W., & de Jong, F.H. (1991). The Endocrine
Effects of Long-Term Treatment with Mifepristone (RU 486). Journal
of Clinical Endocrinology & Metabolism , 73 , 187–191.
Liposits, Z., Uht, R.M., Harrison, R.W., Gibbs, F.P., Paull, W.K., &
Bohn, M.C. (1987). Ultrastructural localization of glucocorticoid
receptor (GR) in hypothalamic paraventricular neurons synthesizing
corticotropin releasing factor (CRF). Histochemistry , 87 ,
407–412.
Lloyd, R.B., & Nemeroff, C.B. (2011). The role of
corticotropin-releasing hormone in the pathophysiology of depression:
therapeutic implications, Current Topics in Medicinal Chemistry ,11 , 609–617.
Mattsson, C., Reynolds, R.M., Simonyte, K., Olsson, T., & Walker, B.R.
(2009). Combined receptor antagonist stimulation of the
hypothalamic-pituitary-adrenal axis test identifies impaired negative
feedback sensitivity to cortisol in obese men. Journal of Clinical
Endocrinology & Metabolism , 94 , 1347–1352.
Muglia, L.J., Bethin, K.E., Jacobson, L., Vogt, S.K., & Majzoub, J.A.
(2000). Pituitary-adrenal axis regulation in CRH-deficient mice.Endocrine Research , 26 , 1057-1066.
Murck, H., Büttner, M., Kircher, T., & Konrad, C. (2014). Genetic,
molecular and clinical determinants for the involvement of aldosterone
and its receptors in major depression. Nephron Physiology ,128 , 17–25.
Nemeroff, C.B., Bissette, G., Akil, H., & Fink, M. (1991). Neuropeptide
concentrations in the cerebrospinal fluid of depressed patients treated
with electroconvulsive therapy. Corticotrophin-releasing factor,
betaendorphin and somatostatin. British Journal of Psychiatry ,158 , 59–63.
Nguyen, E.T., Streicher, J., Berman, S., Caldwell, J.L., Ghisays, V.,
Estrada CM, … Solomon MB. (2017). A mixed
glucocorticoid/mineralocorticoid receptor modulator dampens endocrine
and hippocampal stress responsivity in male rats. Physiology &
Behavior , 178 , 82–92.
Pandey, G.N., Rizavi, H.S., Bhaumik, R., & Ren, X. (2019). Increased
protein and mRNA expression of corticotropin-releasing factor (CRF),
decreased CRF receptors and CRF binding protein in specific postmortem
brain areas of teenage suicide subjects.Psychoneuroendocrinology , 106 , 233–243.
Paxinos, G.A., Watson, C. (1998). The Rat Brain in Stereotaxic
Coordinates. San Diego, California: Academic Press.
Porsolt, R.D., Le Pichon, M., & Jalfre, M. (1977). Depression: a new
animal model sensitive to antidepressant treatments. Nature ,266 , 730–732.
Snyder, J.S., Soumier, A., Brewer, M., Pickel, J., & Cameron, H.A.
(2011). Adult hippocampal neurogenesis buffers stress responses and
depressive behavior. Nature , 476 , 458–461.
Spencer, R., Kim, P., Klaman, B., & Cole, M. (1998). Evidence for
mineralocorticoid receptor facilitation of glucocorticoid
receptor-dependent regulation of hypothalamic-pituitary-adrenal axis
activity. Endocrinology , 139 , 2718–2726.
Uht, R.M., McKelvy, J.F., Harrison, R.W., & Bohn, M.C. (1988).
Demonstration of glucocorticoid receptor-like immunoreactivity in
glucocorticoid-sensitive vasopressin and corticotropin-releasing factor
neurons in the hypothalamic paraventricular nucleus. Journal of
Neuroscience Research , 19 , 405–469.
Ulrich-Lai, Y.M., & Herman, J.P. (2009). Neural regulation of endocrine
and autonomic stress responses. Nature Reviews Neuroscience ,10 , 397–409.
Wang, Z.J., Zhang, X.Q., Cui, X.Y., Cui, S.Y., Yu, B., Sheng, Z.F.,
… Zhang, Y.H. (2015). Glucocorticoid receptors in the locus
coeruleus mediate sleep disorders caused by repeated corticosterone
treatment. Scientific Reports , 5 , 9442.
Wu, T.C., Chen, H.T., Chang, H.Y., Yang, C.Y., Hsiao, M.C., Cheng, M.L.,
& Chen, J.C. (2013). Mineralocorticoid receptor antagonist
spironolactone prevents chronic corticosterone induced depression-like
behavior. Psychoneuroendocrinology , 38 , 871–883.